Publications by authors named "Jeremy Sen"

10Publications

Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patients.

J Oncol Pharm Pract 2020 Jul 26;26(5):1200-1212. Epub 2020 Apr 26.

Division of Hematology/Oncology, Department of Medicine, University of Virginia, Charlottesville, USA.

View Article and Find Full Text PDF
July 2020

A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.

Cancer Manag Res 2019 30;11:8065-8072. Epub 2019 Aug 30.

Division of Hematology/Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.

View Article and Find Full Text PDF
August 2019

Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines.

J Oncol Pharm Pract 2020 Apr 9;26(3):680-687. Epub 2019 Sep 9.

Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, USA.

View Article and Find Full Text PDF
April 2020

Establishing an Antifungal Program to Reduce Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Receiving Induction and Reinduction Chemotherapy.

J Oncol Pract 2018 Nov 15:JOP1800307. Epub 2018 Nov 15.

University of Virginia Health System, Charlottesville, VA; Atlanta Cancer Care, Atlanta, GA; and Medical University of South Carolina, Charleston, SC.

View Article and Find Full Text PDF
November 2018

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date.

Patient Relat Outcome Meas 2018 2;9:329-337. Epub 2018 Oct 2.

Department of Medicine, Division of Hematology/Oncology,

View Article and Find Full Text PDF
October 2018

Risk of Major Bleeding with Ibrutinib.

Clin Lymphoma Myeloma Leuk 2018 11 1;18(11):755-761. Epub 2018 Aug 1.

Division of Hematology-Oncology, Department of Medicine and Cancer Center, University of Virginia Health System, Charlottesville, VA.

View Article and Find Full Text PDF
November 2018

Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors.

Clin Colorectal Cancer 2014 Jun 27;13(2):127-30. Epub 2013 Dec 27.

Division of Hematology/Oncology, Department of Medicine and the UVA Cancer Center, University of Virginia Health System, Charlottesville, VA.

View Article and Find Full Text PDF
June 2014

Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.

Clin Cancer Res 2012 May 5;18(9):2591-602. Epub 2012 Mar 5.

Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

View Article and Find Full Text PDF
May 2012